회사 개요
HealthEquity, Inc. operates as a provider of technology-enabled services platforms, delivering health savings accounts and automated investment advisory tools to consumers and employers across the United States. The company functions within the healthcare sector, specifically specializing in the health information services industry, which focuses on managing and optimizing financial benefits related to health care. Its current market capitalization stands at $7.19B, supported by a trailing twelve-month revenue of $1.31B and an employee base of 2,814 individuals. These valuation and revenue figures indicate that the firm holds a substantial position in its niche, reflecting significant market recognition and operational scale within the specialized health information services landscape.
재무 건전성
The company reported a revenue of $1.31B for the trailing twelve months, generating a net income of $215.20M and an EBITDA of $482.14M, revealing a cost structure where operating expenses and taxes consume a significant portion of top-line growth. The EBITDA figure of $482.14M stands nearly double the net income, highlighting the impact of interest and tax obligations on the bottom line. Free cash flow amounts to $338.05M, providing the firm with considerable financial flexibility to fund operations, reduce debt, or pursue strategic opportunities without immediate reliance on external financing. The gross margin is recorded at 69.5%, while the operating margin sits at 21.6% and the profit margin at 16.4%, indicating a business model with high initial value capture that is subsequently reduced by substantial operating costs and taxes. On the balance sheet, the company holds $318.93M in cash against $1.00B in debt, resulting in a debt-to-equity ratio of 47.53%, which suggests a leveraged capital structure rather than a conservative, cash-heavy stance. Despite the debt load, the current ratio of 3.27 demonstrates robust short-term liquidity, as current assets are more than three times current liabilities. Management effectiveness is further evidenced by a return on equity of 10.2% and a return on assets of 6.0%, showing that the company generates moderate returns on the capital invested by shareholders and utilized in its operations.
밸류에이션 평가
Valuation metrics reveal a trailing P/E ratio of 34.23 compared to a forward P/E of 15.76, implying that the market expects a dramatic expansion in earnings over the coming year that would significantly compress the multiple. The price-to-book ratio is 3.40, suggesting the stock trades at a substantial premium over its book value, reflecting intangible assets or growth expectations not captured on the balance sheet. Alternative valuation measures such as a price-to-sales ratio of 5.48 and an EV/EBITDA of 16.17 provide additional context, indicating that investors are willing to pay a high multiple for the company's revenue generation and earnings power. The stock has historically traded between a 52-week high of $116.65 and a 52-week low of $72.76, with recent price action often fluctuating within this wide range that reflects the market's reaction to earnings volatility. The beta value of 0.26 indicates that the stock exhibits low price volatility relative to the broader market, moving with significantly less intensity than the overall index.
Growth & Income
Revenue growth for the trailing twelve months stands at 7.3%, while earnings growth reaches 92.4%, demonstrating that profitability is expanding at a rate far exceeding top-line sales growth. This divergence implies that recent earnings increases are likely driven by margin expansion, cost efficiencies, or one-time items rather than pure volume increases. As the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, all generated earnings are retained and reinvested directly into business growth and capital expenditures. Consequently, the overall growth and income profile is characterized by aggressive earnings acceleration funded entirely through internal retention rather than shareholder distributions.
동종업체 비교
HealthEquity, Inc. (HQY) 은(는) 의료 정보 서비스 산업에서 운영됩니다. 시가총액 기준으로 가장 가까운 동종업체와의 비교는 다음과 같습니다:
의료 정보 서비스 산업 평균 PER은 57.5배입니다. HealthEquity, Inc.의 PER은 35.5입니다.